Finally, how NUCB1 contributes to PDAC cancer progression, as well as the mechanism through which it influences the anti-tumor effects of gemcitabine in pancreatic cancer cells, have yet to be elucidated. Here, NUCB1 is linked to familial pancreatic carcinoma.